Postmenopausal women on tirzepatide show lower weight loss than those typically seen with the obesity drug, but weight loss ...

By Dennis Thompson HealthDay ReporterMONDAY, July 14, 2025 (HealthDay News) — Good news for women of a certain age: Hormone ...

WW International relists on Nasdaq, pivoting to menopause care with GLP-1 drugs and coaching. Click here to read an analysis ...

Using tirzepatide and menopause hormone therapy at the same time leads to increased weight loss in postmenopausal women with ...

Among 120 women with overweight or obesity, MHT users lost 19.18% of their total body weight with tirzepatide (Mounjaro, ...

Concurrent use of menopausal hormone therapy may augment the weight loss benefits of tirzepatide for postmenopausal women ...

Obesity-related cancer deaths increased more than threefold between 1999 and 2020, according to an analysis of the CDC WONDER ...

Postmenopausal women struggling with weight loss may find a powerful solution by combining the diabetes drug tirzepatide with menopause hormone therapy. A Mayo Clinic study revealed that this dual ...

After menopause, individuals with cardiovascular disease and weight gain may face a higher risk of breast cancer, recent ...

A recent study discovered that obesity increases the risk of breast cancer in women with existing cardiac disease following ...

EXCLUSIVE: Top doctor Dr Kim Boyd says its programmes are needed 'more than ever' despite the boom in weight loss drugs.

WeightWatchers has appointed Dr. Kim Boyd as chief medical officer and announced a new program focused on helping women ...